Evidence map›Paper›PMID 19215822›Full record

ArticleInternational journal of radiation oncology, biology, physics2009

Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response.

David J Grdina, Jeffrey S Murley, Yasushi Kataoka, Kenneth L Baker, Rangesh Kunnavakkam, Mitchell C Coleman, Douglas R Spitz

Open access · greenAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Emerging targets for radioprotection and radiosensitization in radiotherapy.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Radiation-induced chronic oxidative renal damage can be reduced by amifostine.Medical oncology (Northwood, London, England) · 2012
    Article
  14. Article
  15. Article
  16. Article
  17. Salen Mn complexes mitigate radiation injury in normal tissues.Anti-cancer agents in medicinal chemistry · 2011
    Review
  18. Modifying radiation damage.Current drug targets · 2010
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

David J GrdinaDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA. dgrdina@uchicago.edu
Jeffrey S Murley
Yasushi Kataoka
Kenneth L Baker
Rangesh Kunnavakkam
Mitchell C Coleman
Douglas R Spitz
University of Chicago · USUniversity of Iowa · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
Delayed Radioprotection by ThiolsR01CA099005 · NCI · UNIVERSITY OF CHICAGO · PI GRDINA, DAVID J. · 2003 to 2006
$1.2M
NCI NIH HHS P01 CA086862NCI NIH HHS P30 CA086862NCI NIH HHS R01 CA099005NCI NIH HHS R01 CA99005
6 · The paper itself

Abstract

purposeTo determine whether amifostine can induce elevated manganese superoxide dismutase (SOD2) in murine tissues and a transplantable SA-NH tumor, resulting in a delayed tumor cell radioprotective effect. METHODS AND MATERIALS: SA-NH tumor-bearing C3H mice were treated with a single 400 mg/kg or three daily 50 mg/kg doses of amifostine administered intraperitoneally. At selected time intervals after the last injection, the heart, liver, lung, pancreas, small intestine, spleen, and SA-NH tumor were removed and analyzed for SOD2, catalase, and glutathione peroxidase (GPx) enzymatic activity. The effect of elevated SOD2 enzymatic activity on the radiation response of SA-NH cells was determined.

resultsSOD2 activity was significantly elevated in selected tissues and a tumor 24 h after amifostine treatment. Catalase and GPx activities remained unchanged except for significant elevations in the spleen. GPx was also elevated in the pancreas. SA-NH tumor cells exhibited a twofold elevation in SOD2 activity and a 27% elevation in radiation resistance. Amifostine administered in three daily fractions of 50 mg/kg each also resulted in significant elevations of these antioxidant enzymes.

conclusionsAmifostine can induce a delayed radioprotective effect that correlates with elevated levels of SOD2 activity in SA-NH tumor. If limited to normal tissues, this delayed radioprotective effect offers an additional potential for overall radiation protection. However, amifostine-induced elevation of SOD2 activity in tumors could have an unanticipated deleterious effect on tumor responses to fractionated radiation therapy, given that the radioprotector is administered daily just before each 2-Gy fractionated dose.

Indexed as

AmifostineAnimalsCatalaseFemaleGlutathione PeroxidaseLiverLungMercaptoethylaminesMiceMice, Inbred C3HMyocardiumPancreasRadiation-Protective AgentsRadiation ToleranceSarcoma, ExperimentalSuperoxide DismutaseAmifostineCatalaseGlutathione PeroxidaseMercaptoethylaminesN-(2-mercaptoethyl)-1,3-diaminopropaneRadiation-Protective AgentsSuperoxide DismutaseSuperoxide Dismutase 2

Identifiers

PMID19215822
PMCPMC2668222
OpenAlexW1996617516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.